Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06443385 · ClinicalTrials.gov registry record · NA
E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs
A NA study of Opioid Prescribing and Prescription Drug Misuse, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 7,872
- Enrollment target
- 1
- Study location
NCT06443385 is a NA study of Opioid Prescribing and Prescription Drug Misuse that has completed, run by Columbia University. The registered enrollment target is 7,872 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06443385, a NA study of Opioid Prescribing and Prescription Drug Misuse, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,872 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test e-mails to encourage engagement with the Minnesota prescription monitoring program (PMP/PDMP) and will evaluate the effect of these e-mails on PMP/PDMP use and controlled substance prescribing.
Conditions Studied
Interventions
- BEHAVIORAL PDMP Legal Mandate E-mail
- BEHAVIORAL PDMP Clinical Benefit E-mail
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,872 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2025-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06443385
The ClinicalTrials.gov registry entry for NCT06443385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,872 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Prescribing appearing as the primary indexed condition, and to 2 interventions - of which PDMP Legal Mandate E-mail is the first listed.
NCT06443385 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06443385 about?
NCT06443385 is a clinical study titled "E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs". This study will test e-mails to encourage engagement with the Minnesota prescription monitoring program (PMP/PDMP) and will evaluate the effect of these e-mails on PMP/PDMP use and controlled substance prescribing.
What is the current status of trial NCT06443385?
This trial is currently completed. It is a NA study. The enrollment target is 7,872 participants. The study started on 2024-07-17. Estimated completion is 2025-09-24.
What conditions does trial NCT06443385 study?
This clinical trial studies the following conditions: Opioid Prescribing, Prescription Drug Misuse.
What interventions are being tested in trial NCT06443385?
The interventions under investigation include: PDMP Legal Mandate E-mail (BEHAVIORAL), PDMP Clinical Benefit E-mail (BEHAVIORAL).
Who is sponsoring clinical trial NCT06443385?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06443385 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Prescribing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.